BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 9693223)

  • 1. Intrahepatic modulation of portal pressure and its role in portal hypertension.
    Wheatley AM; Zhang X
    Digestion; 1998; 59(4):424-8. PubMed ID: 9693223
    [No Abstract]   [Full Text] [Related]  

  • 2. [The improved method of portal decompression by liver cirrhosis in vivo].
    Abdurakhmanov BA; Gantsev ShKh; Kulakeev OK
    Khirurgiia (Mosk); 2011; (5):39-42. PubMed ID: 21606920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamics in the microvasculature of thioacetamide-induced cirrhotic rat livers.
    Nakata M; Nakamura K; Koda Y; Kaminou T; Ugami M; Kaneda K; Yamada R
    Hepatogastroenterology; 2002; 49(45):652-6. PubMed ID: 12063962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the pathogenesis of portal hypertension in cirrhosis of the liver.
    Shibayama Y
    Liver; 1988 Apr; 8(2):95-9. PubMed ID: 3367713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic flow parameters measured with MR imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension.
    Annet L; Materne R; Danse E; Jamart J; Horsmans Y; Van Beers BE
    Radiology; 2003 Nov; 229(2):409-14. PubMed ID: 12970464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrahepatic modulation of portal pressure and its role in portal hypertension. Role of nitric oxide.
    Gupta TK; Toruner M; Groszmann RJ
    Digestion; 1998; 59(4):413-5. PubMed ID: 9693220
    [No Abstract]   [Full Text] [Related]  

  • 7. Nebivolol treatment increases splanchnic blood flow and portal pressure in cirrhotic rats via modulation of nitric oxide signalling.
    Reiberger T; Payer BA; Schwabl P; Hayden H; Horvatits T; Jäger B; Hummel T; Mitterhauser M; Trauner M; Fuhrmann V; Angermayr B; Peck-Radosavljevic M;
    Liver Int; 2013 Apr; 33(4):561-8. PubMed ID: 23331709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular deterioration in cirrhosis: the big picture.
    Bosch J
    J Clin Gastroenterol; 2007; 41 Suppl 3():S247-53. PubMed ID: 17975472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relation of periportal fibrosis to portal hypertension.
    Shibayama Y; Nakata K
    J Hepatol; 1990 Nov; 11(3):313-7. PubMed ID: 2290021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of hepatic stellate cells in the pathogenesis of portal hypertension.
    Marra F; Pinzani M
    Nefrologia; 2002; 22 Suppl 5():34-40. PubMed ID: 12107915
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of glucagon in the gastric hyperdynamic circulation of cirrhotic portal hypertensive rats.
    Yoshida T; Kitano S; Kobayashi M; Mitarai Y; Bandoh T; Shuto K
    Surg Today; 1995; 25(10):906-10. PubMed ID: 8574058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamics in the isolated cirrhotic liver.
    Zipprich A
    J Clin Gastroenterol; 2007; 41 Suppl 3():S254-8. PubMed ID: 17975473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stellate cells and the "reversible component" of portal hypertension.
    de Franchis R
    Dig Liver Dis; 2000 Mar; 32(2):104-7. PubMed ID: 10975782
    [No Abstract]   [Full Text] [Related]  

  • 14. Functional aspects on the pathophysiology of portal hypertension in cirrhosis.
    García-Pagán JC; Gracia-Sancho J; Bosch J
    J Hepatol; 2012 Aug; 57(2):458-61. PubMed ID: 22504334
    [No Abstract]   [Full Text] [Related]  

  • 15. Resveratrol improves intrahepatic endothelial dysfunction and reduces hepatic fibrosis and portal pressure in cirrhotic rats.
    Di Pascoli M; Diví M; Rodríguez-Vilarrupla A; Rosado E; Gracia-Sancho J; Vilaseca M; Bosch J; García-Pagán JC
    J Hepatol; 2013 May; 58(5):904-10. PubMed ID: 23262250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Mechanisms Leading to Splanchnic Vasodilation in Liver Cirrhosis.
    Di Pascoli M; Sacerdoti D; Pontisso P; Angeli P; Bolognesi M
    J Vasc Res; 2017; 54(2):92-99. PubMed ID: 28402977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac involvement in liver cirrhosis.
    Gatta A; Merkel C; Sacerdoti D; Angeli P
    Ann Ital Med Int; 1993; 8(4):244-7. PubMed ID: 8161481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of sinusoidal stenoses in portal hypertension of liver cirrhosis.
    Shibayama Y; Nakata K
    J Hepatol; 1989 Jan; 8(1):60-6. PubMed ID: 2921504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic stellate cells and intrahepatic modulation of portal pressure.
    Mallat A
    Digestion; 1998; 59(4):416-9. PubMed ID: 9693221
    [No Abstract]   [Full Text] [Related]  

  • 20. Reduction of intrahepatic vascular space in the pathogenesis of portal hypertension. In vitro and in vivo studies in the rat.
    Lee SS; Hadengue A; Girod C; Braillon A; Lebrec D
    Gastroenterology; 1987 Jul; 93(1):157-61. PubMed ID: 3582902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.